Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of Dystrophy

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Matsumura, Cintia Yuri ^a   Menezes de Oliveira, Bruno ^b   Durbeej, Madeleine ^b   Marques, Maria Julia ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRATE DEHYDROGENASE; ALPHA ACTIN; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; BISPHOSPHOGLYCERATE MUTASE 2; CALSEQUESTRIN 1; FRUCTOSE BISPHOSPHATE ALDOLASE A; GALECTIN 1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; HEAT SHOCK PROTEIN 47; HEAT SHOCK PROTEIN 75; HISTONE H2A 1H; LIPOCORTIN 1; LIPOCORTIN 5; MALATE DEHYDROGENASE; MURINOGLOBULIN 1; MUSCLE PROTEIN; MYOSIN 4; MYOSIN 9; MYOSIN LIGHT CHAIN 3; MYOSIN LIGHT CHAIN 6B; PEPTIDE; PEROXIREDOXIN 2; PROTEIN DISULFIDE ISOMERASE; RETICULON 4 INTERACTING PROTEIN 1; SARCALUMENIN; SERPIN H1; TROPONIN C; UNCLASSIFIED DRUG; VIMENTIN;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAPHRAGM; DISEASE SEVERITY; DUCHENNE MUSCULAR DYSTROPHY; EXTRAOCULAR MUSCLE; FEMALE; ISOBARIC TAGGING BASED QUANTIFICATION ANALYSIS; MALE; MOUSE; MUSCLE; MUSCLE NECROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEOMICS; UNINDEXED SEQUENCE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE; ANIMAL; C57BL MOUSE; METABOLISM; PATHOLOGY; SKELETAL MUSCLE;

MUS;

ANIMALS; FEMALE; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; PROTEOMICS;

EID: 84879188544     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065831     Document Type: Article

References (77)

1. Engel AG, Yamamoto M, Fischbeck KH (1994) Dystrophinopathies. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2 ed. New York: McGraw-Hill; pp. 1133-1187.
2. Petrof BJ, (1998) The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Molec Cel Biochem 179 (1-2):: 111-123.
3. Biggar DW, (2006) Duchenne Muscular Dystrophy. Pediatr Rev 401: 83-88.
4. Bulfield G, Siller WG, Wight PAL, Moore KJ, (1984) X chromosome-liked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 81: 1189-1192.
5. Durbeej M, Campbell KP, (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 12 (3):: 349-361.
6. Grounds MD, Sorokin L, White J, (2005) Strength at the extracellular matrix-muscle interface. Scand J Med Sci Sports 15: 381-391.
7. Doran P, Dowling P, Donoghue P, Buffini M, Ohlendieck K, (2006) Reduced expression of regucalcin in young and aged mdx diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle. Biochim Biophys Acta 1764 (4):: 773-785.
8. Doran P, Martin G, Dowling P, Jockusch H, Ohlendieck K, (2006) Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP. Proteomics 6 (16):: 4610-4621.
9. Doran P, Donoghue P, O'Connell K, Gannon J, Ohlendieck K, (2009) Proteomics of skeletal muscle aging. Proteomics 9 (4):: 989-1003.
10. Lewis C, Jockusch H, Ohlendieck K, (2010) Proteomic profiling of the dystrophin-deficient mdx heart reveals drastically altered levels of key metabolic and contractile proteins. J Biomed Biotech pp. 648501.
11. Lewis C, Ohlendieck K, (2010) Proteomic profiling of naturally protected extraocular muscles from the dystrophin-deficient mdx mouse. Biochem Biophys Res Commun 396 (4):: 1024-1029.
12. Gardan-Salmon D, Dixon JM, Lonergan SM, Selsby JT, (2011) Proteomic assessment of the acute phase of dystrophin deficiency in mdx mice. Eur J Appl Physiol 111 (11):: 2763-2773.
13. Carberry S, Zweyer M, Swandulla D, Ohlendieck K, (2012) Proteomics reveals drastic increase of extracellular matrix proteins collagen and dermatopontin in the aged mdx diaphragm model of Duchenne muscular dystrophy. Int J Mol Med 30 (2):: 229-234.
14. Ge Y, Molloy MP, Chamberlain JS, Andrews PC, (2003) Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity. Proteomics 3 (10):: 1895-1903.
15. Doran P, Gannon J, O'Connell K, Ohlendieck K, (2007) Proteomic profiling of animal models mimicking skeletal muscle disorders. Proteomics Clin Appl 1: 1169-84.
16. Thompson A, Schäfer J, Kuhn K, Kienle S, Schwarz J, et al. (2003) Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 75 (8):: 1895-904.
17. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, et al. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 3: 1154-69.
18. Aggarwal K, Choe LH, Lee KH, (2005) Quantitative analysis of protein expression using amine-specific isobaric tags in Escherichia coli cells expressing rhsA elements. Proteomics 5 (9):: 2297-2308.
19. Martins de Souza D, Oliveira BM, Castro-Dias E, Winck FV, Horiuchi RS, et al. (2008) The untiring search for the most complete proteome representation: reviewing the methods. Brief Funct Genomic Proteomic 7 (4):: 312-321.
20. Geiser L, Vaezzadeh AR, Deshusses JM, Hochstrasser DF, (2011) Shotgun proteomics: a qualitative approach applying isoelectric focusing on immobilized pH gradient and LC-MS/MS. Methods Mol Biol 681: 449-58.
21. Lewis C, Doran P, Ohlendieck K, (2012) Proteomic analysis of dystrophic muscle. Methods Mol Biol 798: 357-69.
22. Bantscheff M, Schirle M, Sweetman G, Rick J, Kuster B, (2007) Quantitative mass spectrometry in proteomics: a critical review. Anal Bioanal Chem 389 (4):: 1017-1031.
23. Yates JR, Ruse CI, Nakorchevsky A, (2009) Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng 11: 49-79.
24. Aggarwal K, Choe LH, Lee KH, (2006) Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomic Proteomic 5 (2):: 112-120.
25. Reutenauer-Patte J, Boittin FX, Patthey-Vuadens O, Ruegg UT, Dorchies OM, (2012) Urocortins improve dystrophic skeletal muscle structure and function through both PKA- and Epac-dependent pathways. Am J Pathol 180 (2):: 749-762.
26. Stedman HH, Sweeney HL, Shrager JB, Maguire HC, Panettieri RA, et al. (1991) The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy. Nature 352 (6335):: 536-539.
27. Grounds MD, Radley HG, Lynch GS, Nagaraju K, De Luca A, (2008) Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis 31: 1-19.
28. Taniguti AP, Pertille A, Matsumura CY, Santo Neto H, Marques MJ, (2011) Prevention of muscle fibrosis and myonecrosis in mdx mice by suramin, a TGF-β1 blocker. Muscle Nerve 43 (1):: 82-87.
29. Andrade FH, Porter JD, Kaminski HJ, (2004) Eye muscle sparing by the muscular dystrophies: lessons to be learned? Micros Res Tec 48: 192-203.
30. Storey JD, Tibshirani R, (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100 (16):: 9440-9445.
31. Pertille A, Tonizza de Carvalho CL, Matsumura CY, Santo Neto H, Marques MJ, (2010) Calcium-binding proteins in skeletal muscles of the mdx mice: potential role in the pathogenesis of Duchenne muscular dystrophy. Int J Exp Pathol 91 (1):: 63-71.
32. Dowling P, Lohan J, Ohlendieck K, (2003) Comparative analysis of Dp427-deficient mdx tissues shows that the milder dystrophic phenotype of extraocular and toe muscle fibres is associated with a persistent expression of beta-dystroglycan. Eur J Cell Biol 82 (5):: 222-230.
33. Yoon JH, Johnson E, Xu R, Martin LT, Martin PT, et al. (2012) Comparative proteomic profiling of dystroglycan-associated proteins in wild type, mdx, and Galgt2 transgenic mouse skeletal muscle. J Proteome Res 11 (9):: 4413-24.
34. Wu WW, Wang G, Baek SJ, Shen RF, (2006) Comparative study of three proteomic quantitative methods, DIGE, cICAT, and iTRAQ, using 2D gel- or LC-MALDI TOF/TOF. J Proteome Res 5 (3):: 651-658.
35. Fountoulakis M, Juranville JF, Berndt P, Langen H, Suter L, (2000) Two-dimensional database of mouse liver proteins. An update. Electrophoresis 22 (9):: 1747-1763.
36. Fountoulakis M, Berndt P, Langen H, Suter L, (2002) The rat liver mitochondrial proteins. Electrophoresis 23 (2):: 311-328.
37. Doran P, Dowling P, Lohan J, McDonnell K, Poetsch S, et al. (2004) Subproteomics analysis of Ca2+-binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle. Eur J Biochem 271 (19):: 3943-3952.
38. Kubota K, Kosaka T, Ichikawa K, (2005) Combination of two-dimensional electrophoresis and shotgun peptide sequencing in comparative proteomics. J Chromatogr B Analyt Technol Biomed Life Sci 815 (1-2):: 3-9.
39. Malmström J, Lee H, Aebersold R, (2007) Advances in proteomic workflows for systems biology. Curr Opin Biotechnol 18 (4):: 378-384.
40. Ferretti R, Marques MJ, Pertille A, Santo Neto H, (2009) Sarcoplasmic-endoplasmic-reticulum Ca2+-ATPase and calsequestrin are overexpressed in spared intrinsic laryngeal muscles of dystrophin-deficient mdx mice. Muscle Nerve 39 (5):: 609-615.
41. Dowling P, Doran P, Ohlendieck K, (2004) Drastic reduction of sarcalumenin in Dp427-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy. Biochem J 379: 479-488.
42. Rossi AE, Dirksen RT, (2006) Sarcoplasmatic reticulum: the dynamic calcium governor of muscle. Muscle Nerve 33: 715-731.
43. Porter JD, Merriam AP, Khanna S, Andrade AH, Richmonds CR, et al. (2003) Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice. FASEB J 17: 893-895.
44. Rhee SG, (2005) Chae HZ, Kim K, (2005) Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med 38 (12):: 1543-52.
45. Craig EA, Gambill BD, Nelson RJ, (1993) Heat-shock proteins: molecular chaperones of protein biogenesis. Mol Cell Biol 13: 5637-5646.
46. Banfi G, Dolci A, Verna R, Corsi MM, (2004) Exercise raises serum heat-shock protein 70 (Hsp70) levels. Clin Chem Lab Med 42: 1445-1446.
47. Paepe BD, Creus KK, Weis J, Bleecker JL, (2012) Heat shock protein families 70 and 90 in Duchenne muscular dystrophy and inflammatory myopathy: balancing muscle protection and destruction. Neuromuscul Disord 22 (1):: 26-33.
48. Razzaque1 MS, Taguchi T, (1999) The possible role of colligin/HSP47, a collagen-binding protein, in the pathogenesis of human and experimental fibrotic diseases. Histol Histopathol 14: 1199-1212.
49. Gerke V, Creutz CE, Moss SE, (2005) Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 6 (6):: 449-461.
50. McNeil AK, Rescher U, Gerke V, McNeil PL, (2006) Requirement for annexin A1 in plasma membrane repair. J Biol Chem 281 (46):: 35202-35207.
51. Waddell LB, Lemckert FA, Zheng XF, Tran J, Evesson FJ, et al. (2011) Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch. J Neuropathol Exp Neurol 70 (4):: 302-313.
52. Gerke V, Moss S, (2002) Annexins: from structure to function. Physiol Rev 82 (2):: 331-371.
53. van Genderen HO, Kenis H, Hofstra L, Narula J, Reutelingsperger CP, (2008) Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta 1783 (6):: 953-963.
54. Probst-Cousin S, Berghoff C, Neundörfer B, Heuss D, (2004) Annexin expression in inflammatory myopathies. Muscle Nerve 30 (1):: 102-110.
55. Flower RJ, (1988) Lipocortin and the mechanisms of action of the glucocorticoids. Br J Pharmacol 94: 987-1015.
56. Goulding NJ, Guyre PM, (1993) Glucocorticoids, lipocortins and the immune response. Curr Opin Immunol 5: 108-113.
57. Parente L, Solito E, (2004) Annexin 1: more than an anti-phospholipase protein. Inflamm Res 53: 125-132.
58. Reutelingsperger CP, van Heerde WL, (1997) Annexin V, the regulator of phosphatidylserine-catalyzed inflammation and coagulation during apoptosis. Cell Mol Life Sci 53: 527-532.
59. Buckland AG, Wilton DC, (1998) Inhibition of human cytosolic phospholipase A2 by human annexin V. Biochem J 329: 369-372.
60. Li Q, Qi B, Oka K, Shimakage M, Yoshioka N, et al. (2001) Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene 20: 3929-3936.
61. Tagami S, Eguchi Y, Kinoshita M, Takeda M, Tsujimoto Y, (2000) A novel protein, RTN-XS, interacts with both Bcl-XL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 19: 5736-5746.
62. Tidball JG, Albrecht DE, Lokensgard BE, (1995) Spencer, M. J. Apoptosis precedes necrosis of dystrophin-deficient muscle. J Cell Sci 108: 2197-204.
63. Matsuda RA, Nishikawa A, Tanaka H, (1995) Vizualization of dystrophic muscle fibers in mdx mouse by vital staining with Evans blue: evidence of apoptosis in dystrophin-deficient muscle. J Bioch 118: 959-964.
64. Sandri M, Podhorska-Okolow M, Geromel V, Rizzi C, Arslan P, et al. (1997) Exercise induces myonuclear ubiquitination and apoptosis in dystrophin-deficient muscle of mice. J Neuropathol Exp Neurol 56: 45-57.
65. Tews DS, Goebel HH, (1977) DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies. Neuropathol Appl Neurobiol 23: 331-338.
66. Pereira JA, Taniguti AP, Matsumura C, Marques MJ, Neto HS, (2012) Doxycycline ameliorates the dystrophic phenotype of skeletal and cardiac muscles in mdx mice. Muscle Nerve 46 (3):: 400-406.
67. Abmayr S, Crawford RW, Chamberlain JS, (2004) Characterization of ARC, apoptosis repressor interacting with CARD, in normal and dystrophin-deficient skeletal muscle. Hum Mol Genet 13 (2):: 213-221.
68. Dominov JA, Kravetz AJ, Ardelt M, Kostek CA, Beermann ML, et al. (2005) Muscle-specific BCL2 expression ameliorates muscle disease in laminin α2-deficient, but not in dystrophin-deficient, mice. Hum Mol Genet 14 (8):: 1029-1040.
69. Goldring K, Jones GE, Thiagarajah R, Watt DJ, (2002) The effect of galectin-1 on the differentiation of fibroblasts and myoblasts in vitro. J Cell Sci 115 (2):: 355-366.
70. Stowell SR, Arthur CM, Mehta P, Slanina KA, Blixt O, et al. (2008) Galectin-1,-2, and-3 exhibit differential recognition of sialylated glycans and blood group antigens. J Biol Chem 283: 10109-10123.
71. Nowak TP, Haywood PL, Barondes SH, (1976) Developmentally regulated lectin in embryonic chick muscle and a myogenic cell line. Biochem Biophys Res Commun 68: 650-657.
72. Barondes SH, Haywood-Reid PL, (1981) Externalization of an endogenous chicken muscle lectin with in vivo development. J Cell Biol 91: 568-572.
73. Cooper DN, Barondes SH, (1990) Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol 110 (5):: 1681-1691.
74. Harrison FL, Wilson TJ, (1992) The 14 kDa beta-galactoside binding lectin in myoblast and myotube cultures: Localization by confocal microscopy. J Cell Sci 101: 635-646.
75. Poirier F, Timmons PM, Chan CT, Guénet JL, Rigby PW, (1992) Expression of the L14 lectin during mouse embryogenesis suggests multiple roles during pre- and post-implantation development. Development 115: 143-155.
76. Watt DJ, Jones GE, Goldring K, (2004) The involvement of galectin-1 in skeletal muscle determination, differentiation and regeneration. Glycoconj J 19: 615-619.
77. Rabinovich GA, Sotomayor CE, Riera CM, Bianco I, Correa SG, (2000) Evidence of a role for galectin-1 in acute inflammation. Eur J Immunol 30: 1331-1339.